Morphine is an analgesic drug therapeutically administered to relieve pain. However, this drug has numerous side effects, which include impaired healing and regeneration after injuries or tissue damages. It suggests negative effects of morphine on stem cells which are responsible for tissue regeneration. Therefore, we studied the impact of morphine on the properties and functional characteristics of human bone marrow-derived mesenchymal stem cells (MSCs). The presence of μ-, δ- and κ-opioid receptors (OR) in untreated MSCs, and the enhanced expression of OR in MSCs pretreated with proinflammatory cytokines, was demonstrated using immunoblotting and by flow cytometry. Morphine modified in a dose-dependent manner the MSC phenotype, inhibited MSC proliferation and altered the ability of MSCs to differentiate into adipocytes or osteoblasts. Furthermore, morphine rather enhanced the expression of genes for various immunoregulatory molecules in activated MSCs, but significantly inhibited the production of the vascular endothelial growth factor, hepatocyte growth factor or leukemia inhibitory factor. All of these observations are underlying the selective impact of morphine on stem cells, and offer an explanation for the mechanisms of the negative effects of opioid drugs on stem cells and regenerative processes after morphine administration or in opioid addicts.

Department of Biochemistry Faculty of Science Charles University 128 43 Prague 2 Czech Republic

Department of Biomathematics Institute of Physiology of the Czech Academy of Sciences 4 142 20 Prague Czech Republic

Department of Cell Biology Faculty of Science Charles University 128 43 Prague 2 Czech Republic

Department of Transplantation Immunology Institute of Experimental Medicine of the Czech Academy of Sciences 4 142 20 Prague Czech Republic

Zobrazit více v PubMed

Cytokine Growth Factor Rev. 2015 Oct;26(5):533-44 PubMed

Circ J. 2012;76(1):204-12 PubMed

Immunol Cell Biol. 2013 Jan;91(1):19-26 PubMed

Stem Cells. 2016 Jul;34(7):1909-21 PubMed

J Neuroimmunol. 2018 Aug 15;321:12-23 PubMed

Anesth Analg. 2008 Aug;107(2):686-92 PubMed

Cell Res. 2015 Mar;25(3):275-87 PubMed

PLoS One. 2014 Jul 29;9(7):e103043 PubMed

Cancer Cell Microenviron. 2015;2(3):null PubMed

Stem Cell Rev. 2016 Dec;12(6):654-663 PubMed

Neurosci Lett. 2017 Jan 1;636:205-212 PubMed

J Immunol. 2008 Feb 15;180(4):2581-7 PubMed

Cytotherapy. 2006;8(4):315-7 PubMed

J Neurochem. 2010 Mar;112(6):1431-41 PubMed

Drug Alcohol Depend. 2015 Nov 1;156:139-149 PubMed

Gut. 2018 Apr;67(4):600-602 PubMed

Br J Pharmacol. 2018 Jul;175(14):2717-2725 PubMed

Cytotherapy. 2006;8(6):559-61 PubMed

PLoS One. 2017 Oct 20;12(10):e0186797 PubMed

Stem Cell Res Ther. 2016 Sep 09;7(1):131 PubMed

Stem Cell Rev. 2012 Jun;8(2):375-92 PubMed

Sci Rep. 2017 Aug 7;7(1):7442 PubMed

Wound Repair Regen. 2006 Jan-Feb;14(1):2-10 PubMed

Biochem Pharmacol. 2009 Jun 1;77(11):1747-55 PubMed

Neurochem Res. 2016 Jun;41(6):1410-9 PubMed

Stem Cells Transl Med. 2015 Sep;4(9):1052-63 PubMed

Clin Orthop Relat Res. 2013 Dec;471(12):4076-81 PubMed

Toxicol Lett. 2016 Apr 15;247:45-55 PubMed

Cell Transplant. 2016;25(5):829-48 PubMed

Acta Haematol. 2001;106(4):148-56 PubMed

Front Pharmacol. 2017 May 09;8:254 PubMed

Clin Exp Immunol. 2003 Apr;132(1):40-5 PubMed

Biochem Pharmacol. 2007 Sep 1;74(5):752-7 PubMed

The Impact of Metal Nanoparticles on the Immunoregulatory and Therapeutic Properties of Mesenchymal Stem Cells

Expression of Opioid Receptors in Cells of the Immune System